Chronic kidney disease (CKD) is typically associated with severe fibrosis, the exact pathogenesis of which remains unclear.

ZyVersa gains FDA approval for emergency use of VAR 200 in a rare kidney disease case; stock jumps on high trading volume and ...

Case Study Published: April 2009 Focal segmental glomerulosclerosis as a complication of graft-versus-host disease Claudia Fofi, Simona Barberi, Antonella Stoppacciaro, Giorgio Punzo & Paolo Menè ...

Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.

Travere Therapeutics Inc. (NASDAQ: TVTX) is one of the best biotech stocks to invest in now. On June 10, Travere Therapeutics launched a new awareness campaign called ‘Play It Forward’ to support the ...

The two women are scheduled to have the kidney transplant procedure done on Thursday at Tampa General Hospital. TGH says it ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $33.62, along ...

Medical device steriliser Nanosonics is pushing for stronger sales of its flagship device Trophon, ahead of the release of an ...

Armistice Capital holds 8.9M shares in Travere Therapeutics as rare kidney disease stock climbs 110% following FILSPARI's ...

Initiation of patient recruitment marks a key milestone in the development of VAR 200, a potential first-in-class treatment for kidney disease addressing renal lipotoxicity.There are no available ...

Initiation of patient recruitment marks a key milestone in the development of VAR 200, a potential first-in-class treatment for kidney disease addressing renal lipotoxicity.There are no available drug ...

Tetratherix today has listed at a solid premium to its IPO price, raising the hopes of other life science outfits eyeing an ...